Abstract
The origin of intra-ophthalmic artery chemotherapy (SSIOAC) dates back to the 1950s. Cases of advanced intraocular retinoblastoma with (1) large multiple lesions still having enough normal retina so visual preservation was possible, (2) vitreous seeds, or (3) tumors refractory to other treatments presented a challenge for Reese and other early pioneers in the treatment of retinoblastoma, as they unfortunately still do today.
| Original language | English (US) |
|---|---|
| Title of host publication | Clinical Ophthalmic Oncology: Retinoblastoma, Second Edition |
| Publisher | Springer Berlin Heidelberg |
| Pages | 129-136 |
| Number of pages | 8 |
| ISBN (Print) | 9783662434512, 9783662434505 |
| DOIs | |
| State | Published - Jan 1 2015 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Intra-ophthalmic Artery Chemotherapy for Retinoblastoma. / Wilson, Matthew W.; Tse, Brian; Brennan, Rachel C.
Clinical Ophthalmic Oncology: Retinoblastoma, Second Edition. Springer Berlin Heidelberg, 2015. p. 129-136.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Intra-ophthalmic Artery Chemotherapy for Retinoblastoma
AU - Wilson, Matthew W.
AU - Tse, Brian
AU - Brennan, Rachel C.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - The origin of intra-ophthalmic artery chemotherapy (SSIOAC) dates back to the 1950s. Cases of advanced intraocular retinoblastoma with (1) large multiple lesions still having enough normal retina so visual preservation was possible, (2) vitreous seeds, or (3) tumors refractory to other treatments presented a challenge for Reese and other early pioneers in the treatment of retinoblastoma, as they unfortunately still do today.
AB - The origin of intra-ophthalmic artery chemotherapy (SSIOAC) dates back to the 1950s. Cases of advanced intraocular retinoblastoma with (1) large multiple lesions still having enough normal retina so visual preservation was possible, (2) vitreous seeds, or (3) tumors refractory to other treatments presented a challenge for Reese and other early pioneers in the treatment of retinoblastoma, as they unfortunately still do today.
UR - http://www.scopus.com/inward/record.url?scp=84956712039&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84956712039&partnerID=8YFLogxK
U2 - 10.1007/978-3-662-43451-2_12
DO - 10.1007/978-3-662-43451-2_12
M3 - Chapter
AN - SCOPUS:84956712039
SN - 9783662434512
SN - 9783662434505
SP - 129
EP - 136
BT - Clinical Ophthalmic Oncology: Retinoblastoma, Second Edition
PB - Springer Berlin Heidelberg
ER -